WASHINGTON – The U.S. Food and Drug Administration approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite has an ingestible sensor embedded in the pill that records that the medication was taken. “The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers,” said Dr. Mitchell Mathis, director of the division of psychiatry products in the FDA’s Center for Drug Evaluation and Research. The system works by sending a message from the pill’s sensor to a wearable patch, which transmits the information to a mobile app so that patients can track the ingestion of the medication on their smart phone. Patients can also permit their caregivers and physician to access the information through a web-based portal.
You are here: / / FDA approves digital pill